212 filings
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
8-K
MREO
Mereo Biopharma Group Plc
15 May 24
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
ARS
2023 FY
MREO
Mereo Biopharma Group Plc
24 Apr 24
Annual report to shareholders
7:36am
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
8-K
32zz 7v2ytkb5x39vfz
15 Apr 24
Entry into a Material Definitive Agreement
7:30am
10-K
nmf8dtv 174zr3d6ew
27 Mar 24
Annual report
5:20pm
8-K
nuh25a8
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
S-8
14v5co u3h
23 Jan 24
Registration of securities for employees
4:16pm
8-K
jnxb khdtuinofvicd
8 Jan 24
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
7:08am
8-A12B/A
qkcfjihtdim h6fcsd
18 Dec 23
Registration of securities on exchange (amended)
4:16pm
6-K
zbnkz
18 Dec 23
Current report (foreign)
4:10pm
6-K
e4k0ex2
29 Nov 23
Current report (foreign)
4:15pm
6-K
e1kl4a7ps0n8hfl bkvj
16 Nov 23
Current report (foreign)
7:01am
6-K
y7bolv0egih
23 Oct 23
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
4:08pm
6-K
fuy5r1mlk sz
17 Oct 23
Current report (foreign)
7:01am
6-K
68iaq wfv05i2j0769
20 Sep 23
Current report (foreign)
4:03pm
6-K
4bcd79al
7 Sep 23
Current report (foreign)
7:37am
6-K
jy0e7c 4rdtk098xfdim
6 Jul 23
Ultragenyx Announces First Patients Dosed in Phase 3 Program
8:05am
6-K
itpa3cx7o
30 Jun 23
Current report (foreign)
4:05pm